"Designing Growth Strategies is in our DNA"

U.S. Bone Graft Substitutes Market Size, Share & COVID-19 Impact Analysis, By Type (Allograft, Demineralized Bone Matrix (DBM), Synthetic {Polymer, and Ceramic [Hydroxyapatite, Beta TCP, and Others]}, and Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Forecast, 2023-2030

Last Updated: June 03, 2024 | Format: PDF | Report ID: FBI109191

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. bone graft substitutes market size was worth USD 1.51 billion in 2022 and is projected to grow at a CAGR of 6.5% during the forecast period.


Bone graft substitutes are medical devices made from synthetic or natural materials and used to promote bone healing and regeneration in cases of fractures, defects, or spinal fusions. Substitutes, such as hydroxyapatite and demineralized bone matrix, mimic the structural and biochemical properties of a bone, facilitating the body's natural bone formation processes.


The rising prevalence of orthopedic-related diseases is expected to increase the demand for demineralized bone, allograft, and other bone graft substitutes. Furthermore, the rising approval of products used in spinal fusion and other orthopedic procedures by regulatory bodies is expected to fuel the market’s growth in the long run.



  • For instance, in January 2020, OrthoPediatrics Corp. launched QuickPack, a fully synthetic bone graft substitute in the U.S. The product has a high viscosity and calcium phosphate cement that closely mimics the mineral phase of natural bone.


The COVID-19 pandemic caused a decline in the U.S. bone graft substitutes market’s growth. This was mainly due to major delays in conducting elective and non-essential procedures in the country due to the restrictions imposed by the government. Furthermore, a majority of the healthcare resources were used to treat COVID-19 patients, which negatively impacted the market’s growth in 2020.


U.S. Bone Graft Substitutes Market Trends


Increasing Adoption of Bone Graft Substitutes for Dental Implants


In recent years, the market witnessed a sudden spike in the adoption of dental bone grafts in dental implant procedures due to the various benefits associated with them. These products help increase the jawbone's height and thickness, enabling the successful placement of bone graft substitutes and restoring the jawline's normal dimensions in many patients.



  • For instance, according to an article published by Dental Tribune International in June 2021, a large volume of patients demanded implant procedures to improve their dental health and functionality by using artificial components. This is a promising indicator of the growth in the demand for bone grafting procedures.


U.S. Bone Graft Substitutes Market Growth Factors


Technological Advancements in Bone Graft Substitutes to Drive Market Growth


The growing prevalence of orthopedic disorders has encouraged the U.S. bone graft substitutes market players to increase their focus on technological advancements, such as antibiotic-eluting products. These products enable natural bone healing while reducing the recurrence of chronic osteomyelitis from antibiotic-sensitive microorganisms.



  • For instance, in June 2021, Elute, Inc. announced that it had received its first clinical trial authorization from the U.S. FDA for using its antibiotic-eluting bone void filler. The product would treat bone infections as it has osteoconductive and antimicrobial properties.


RESTRAINING FACTORS


Clinical Limitations Associated With Bone Graft Substitutes to Limit Market Growth


The limitations associated with using substitutes include infection of the soft tissue & bone, severe tissue reactions, and lack of or incomplete bone formation. These disadvantages are expected to hamper the adoption of bone graft substitutes during the forecast timeframe.


Furthermore, the increasing awareness of the risks associated with these products has led to product recalls by manufacturers and the U.S. FDA. This can negatively impact the brand image of these companies, thereby reducing the adoption of these products.


Request a Free sample to learn more about this report.


In the U.S., it was estimated that the incidence of fracture and spine degeneration was 9,645,791 and 16,208,664, respectively.


U.S. Bone Graft Substitutes Market Segmentation Analysis


By Type Analysis


Based on type, the market is segmented into allograft, demineralized bone matrix (DBM), synthetic, and xenograft.


The synthetic segment held the highest market share in 2022 and is expected to record the highest CAGR during the forecast period. The increasing adoption of synthetic products, the surge in bone graft-related surgeries, and the high success rate of these products are expected to drive the dominance of this segment.



  • For instance, in April 2019, Exactech announced the first successful surgery using its new InterSep calcium sulfate, a synthetic bone graft product.


The allograft segment held a significant share of the market in 2022. The segment's growth is due to the increasing prevalence of bone-related disorders and the growing focus of market players on launching allografts in the country.


By Application Analysis


Based on application, the market is segmented into spinal fusion, joint reconstruction, foot & ankle, and others.


The spinal fusion segment accounted for the largest U.S. bone graft substitutes market share in 2022. The segment’s growth is due to a notable increase in the number of lumbar fusion surgeries in hospitals. Furthermore, new product launches by market players for the treatment of spinal injuries are expected to boost the segment’s growth in the country.


In 2022, the joint reconstruction segment held a significant share of the market. The segment’s growth is attributed to a larger patient population suffering from arthritis and other joint-related complications.



  • For instance, according to an article published by the American Academy of Orthopedic Surgeons in June 2020, over 450,000 total hip replacement surgeries are performed each year in the U.S.


By End-user Analysis


Based on end-user, the market is segmented into hospitals, specialty clinics, and others.


The specialty clinics segment is projected to record the highest CAGR during the forecast period of 2023-2030. The rising cases of osteosarcoma in the U.S. is expected to increase patient visits to specialty clinics, thereby propelling the segment's growth during the forecast period.



  • For instance, according to the American Cancer Society, Inc., around 1,000 new cases of osteosarcoma were diagnosed in the U.S. in 2023. This factor is expected to increase the number of surgeries in specialty clinics, thereby spurring the segment’s growth.


In 2022, the hospital segment held the largest share of the market. The growth of this segment is attributed to the increasing number of hospitals in the country. Additionally, the increasing number of visits to hospitals of patients suffering from ankylosing spondylitis disorders and bone fractures will increase the demand for bone graft substitutes, thereby propelling the segment’s growth.


List of Key Companies in U.S. Bone Graft Substitutes Market


As far as the competitive landscape is concerned, the U.S. bone graft substitutes market depicts the presence of several reputed companies. Organizations such as DePuy Synthes, Medtronic, Stryker, and Zimmer Biomet are prominent players in the market. The apex positions held by these companies are attributed to their diversified product portfolios, strong geographical presence, and large customer base. Furthermore, strategic initiatives, such as new product launches, mergers, and acquisitions, are expected to help key players maintain and strengthen their positions in the market.


Some other companies with a considerable presence in the U.S. market include MTF Biologics, Smith & Nephew plc, and other small & medium-sized players. These companies are focusing on various strategies, such as launching new bone graft substitutes to strengthen their product portfolio, which is expected to increase their U.S. bone graft substitutes market share.


An Infographic Representation of U.S. Bone Graft Substitutes Market

To get information on various segments, share your queries with us



LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • September 2023: Zimmer Biomet collaborated with HippoFi, a healthcare technology firm in California. The collaboration is aimed at introducing novel synthetic biomaterials for bone growth in 2024.

  • June 2022: NuVasive received approval from the U.S. FDA for ATTRAX, its synthetic bone graft substitute. This product is used in interbody fusions of the thoracolumbar spine.

  • March 2022: MTF Biologics partnered with Bone Biologics Corporation. The partnership was aimed at distributing Bone Biologics Corporation’s Demineralized Bone Matrix (DBM) in the country.


REPORT COVERAGE


The report provides a detailed analysis of the market. It focuses on key aspects, such as an overview of the technological advancements and prevalence of key disorders in the U.S. Additionally, it includes an overview of the key industry developments and the impact of COVID-19 on the market. Moreover, the report provides a comparative analysis of the product portfolio of key companies.


To gain extensive insights into the market, Request for Customization


Report Scope & Segmentation
















































ATTRIBUTE



DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year 



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 6.5% from 2023 to 2030



Unit



Value (USD Billion)



Segmentation



By Type



  • Allograft

  • Demineralized Bone Matrix (DBM)

  • Synthetic

    • Polymer

    • Ceramic

      • Hydroxyapatite

      • Beta TCP

      • Others





  • Xenograft



By Application



  • Spinal Fusion

  • Joint Reconstruction

  • Foot & Ankle

  • Others



By End-user



  • Hospitals

  • Specialty Clinics

  • Others






Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth USD 1.51 billion in 2022.

The market is expected to exhibit a CAGR of 6.5% during the forecast period of 2023-2030.

By type, the synthetic segment accounts for the highest share of the market.

DePuy Synthes Companies (Johnson & Johnson Services, Inc.), Medtronic, Zimmer Biomet, and Stryker are the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 70

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X